SK1795A3 - Drug delivery device and method of this production - Google Patents

Drug delivery device and method of this production Download PDF

Info

Publication number
SK1795A3
SK1795A3 SK17-95A SK1795A SK1795A3 SK 1795 A3 SK1795 A3 SK 1795A3 SK 1795 A SK1795 A SK 1795A SK 1795 A3 SK1795 A3 SK 1795A3
Authority
SK
Slovakia
Prior art keywords
polymer
drug
dosage form
cross
matrix
Prior art date
Application number
SK17-95A
Other languages
English (en)
Slovak (sk)
Inventor
Helle Brondsted
Lars Hovgaard
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of SK1795A3 publication Critical patent/SK1795A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK17-95A 1992-07-07 1993-07-06 Drug delivery device and method of this production SK1795A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK92895A DK89592D0 (da) 1992-07-07 1992-07-07 Laegemiddelafgivelsesindretning samt fremgangsmaade til fremstilling deraf
PCT/DK1993/000227 WO1994001136A1 (en) 1992-07-07 1993-07-06 A drug delivery device and a method of making such device

Publications (1)

Publication Number Publication Date
SK1795A3 true SK1795A3 (en) 1995-09-13

Family

ID=8098759

Family Applications (1)

Application Number Title Priority Date Filing Date
SK17-95A SK1795A3 (en) 1992-07-07 1993-07-06 Drug delivery device and method of this production

Country Status (15)

Country Link
EP (1) EP0648129A1 (ru)
JP (1) JPH07508735A (ru)
KR (1) KR950702437A (ru)
AU (1) AU671651B2 (ru)
BR (1) BR9306700A (ru)
CA (1) CA2139747A1 (ru)
CZ (1) CZ3895A3 (ru)
DK (1) DK89592D0 (ru)
FI (1) FI950065A (ru)
HU (1) HUT75665A (ru)
NZ (1) NZ253678A (ru)
PL (1) PL172724B1 (ru)
RU (1) RU2139093C1 (ru)
SK (1) SK1795A3 (ru)
WO (1) WO1994001136A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783214A (en) * 1994-06-13 1998-07-21 Buford Biomedical, Inc. Bio-erodible matrix for the controlled release of medicinals
WO1998000170A1 (en) * 1996-07-01 1998-01-08 Universiteit Utrecht Hydrolysable hydrogels for controlled release
GEP20053427B (en) 1999-12-23 2005-01-25 Pfizer Prod Inc Pharmaceutical Compositions Providing Enhanced Drug Concentrations
WO2011123416A1 (en) * 2010-03-29 2011-10-06 Surmodics, Inc. Injectable drug delivery formulation
KR20190090048A (ko) 2011-12-05 2019-07-31 인셉트, 엘엘씨 의료용 유기젤 방법 및 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2550750A (en) * 1947-09-22 1951-05-01 Arthur C Abelt Differential for automobiles
US4024073A (en) * 1972-01-08 1977-05-17 Toray Industries, Inc. Hydrogel and production thereof
IT1131833B (it) * 1980-06-20 1986-06-25 Crinos Industria Farmaco Eccipienti per sostanze spermicide
JPS5997346A (ja) * 1982-11-24 1984-06-05 Komatsu Ltd 車両のデイフアレンシヤル装置
SE9002339L (sv) * 1990-07-04 1992-01-05 Kabi Pharmacia Ab Terapeutisk komposition och foerfarande foer dess framstaellning

Also Published As

Publication number Publication date
NZ253678A (en) 1996-07-26
FI950065A (fi) 1995-03-02
BR9306700A (pt) 1998-12-08
AU4417893A (en) 1994-01-31
CA2139747A1 (en) 1994-01-20
PL172724B1 (pl) 1997-11-28
PL307050A1 (en) 1995-05-02
EP0648129A1 (en) 1995-04-19
WO1994001136A1 (en) 1994-01-20
CZ3895A3 (en) 1995-09-13
JPH07508735A (ja) 1995-09-28
HU9500042D0 (en) 1995-03-28
AU671651B2 (en) 1996-09-05
RU2139093C1 (ru) 1999-10-10
FI950065A0 (fi) 1995-01-05
KR950702437A (ko) 1995-07-29
DK89592D0 (da) 1992-07-07
HUT75665A (en) 1997-05-28

Similar Documents

Publication Publication Date Title
RU2093148C1 (ru) Композиции с замедленным (пролонгированным) высвобождением
US6284273B1 (en) Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds
Kamel et al. Pharmaceutical significance of cellulose: A review
Kashyap et al. Hydrogels for pharmaceutical and biomedical applications
KR0157280B1 (ko) 하부소화관 방출성의 경구의약제제
JP2821952B2 (ja) 下部消化管放出性の経口医薬製剤
SK1795A3 (en) Drug delivery device and method of this production
US20230181479A1 (en) Polymer based formulation for release of drugs and bioactives at specific git sites
EP2446877A1 (en) Modified starch derivative-based matrix for colon targeting
WO1997029777A1 (fr) Systeme d'administration de medicament utilisant une galactoxyloglucane
JP2638604B2 (ja) 徐放性製剤
WO2020048979A1 (en) Controlled drug release formulation
Tangde et al. Sustained release matrix type drug delivery systems; a review
JPH0130A (ja) 徐放性製剤
KR100212432B1 (ko) 대장 약물전달 조성물
Singh et al. A Review on Sustained Drug Delivery System: Matrix Tablet
Sharma et al. Various Approaches Used For Colonic Drug Delivery System
Chaurasia et al. Synthetic polymers as biomaterials for the treatment of colon diseases
CN112741801A (zh) 一种新型卡波非聚合物及其给药系统
Garapati et al. Tailoring the Release of Drugs Using Excipients
Reddy Formulation And Evaluation Of Sustained Release Matrix Tablet Of An Anti-Hypertensive Drug